The effect of TRH administration on serum GH was studied in 6 normal subjects, 13 patients with primary hypothyroidism and 6 thyrotoxic subjects. Although no appreciable changes of serum GH were noted in the normal subjects, TRH administration provoked an increase of serum GH in 6 out of 13 patients with primary hypothyroidism.
Synopsis
The effect of TRH administration on serum GH was studied in 6 normal subjects, 13 patients with primary hypothyroidism and 6 thyrotoxic subjects. Although no appreciable changes of serum GH were noted in the normal subjects, TRH administration provoked an increase of serum GH in 6 out of 13 patients with primary hypothyroidism.
Serum GH levels in response to TRH administration were decreased in patients who were euthyroid following treatment with a preparation of desiccated thyroid.
In patients with hyperthyroidism, no significant response of serum GH was observed at 30 or 60 min after TRH administration.
Some of the patients with hyperthyroidism showed a slight increase in serum GH at 120 min after TRH injection.
These results suggest that hypothalamo-pituitary function regulating GH secretion is altered in patients with primary hypothyroidism.
Synthetic thyrotropin releasing hormone (TRH) has been shown to be a potent secretagogue for thyrotropin (TSH) and prolactin in both man (Anderson et al., 1971; Jacobs et al., 1971 ) and other species (Convey, 1973) . Although serum growth hormone (GH) generally shows no appreciable rise following administration of TRH to normal humans (Anderson et al., 1971) , such responses have been described in pathological human states (Irie and Tsushima, 1972; Hasegawa et al., 1975; Maeda et al., 1975 a and b) , in vivo in bovines (Convey, 1973) and rats (Kato et al., 1975) , and in vitro using various animal preparations (Carlson et al., 1974; Machlin and Jacobs, 1973) .
The effect of TRH on the pituitary release of TSH and prolactin is magnified in the presence of reduced circulating thyroid hormone , and Lawrence et al. (1973) reported that some of their patients with primary hypothyroidism showed unusually exaggerated GH response to arginine infusion. This communication reports an abnormal response of serum GH to TRH in patients with primary hypothyroidism. Anderson et al. (1971) , in the study on the effect of TRH in 80 normal subjects, observed a slight rise of mean GH values between 120 and 180 minafter TRH administration, but the rise was not statistically significant. In the present study no appreciable changes of serum GH were noted in the normal subjects and patients with hyperthyroidism. It is very interesting that TRH provoked an increase of serum GH in 6 out of 13 patients with primary hypothyroidism and that the serum GH response to TRH decreased with the return to the euthyroid state. The six patients who showed a rise of serum GH after TRH injection were females and had not had replacement therapy.
Their clinical symptoms of myxedema were severe and the duration of symptoms was longer than one year except for one case. However, other patients with severe symptoms of myxedema did not necessarily show a significant rise of serum GH after TRH administration and serum thyroxine, triiodothyronine resin sponge uptake, cholesterol, BMR and TSH levels did not seem to have a relationship with GH response after TRH administration.
Some explanation for the increased GH response to TRH in patients with primary hypothyroidism is needed, since a significant decrease in the GH response to insulininduced hypoglycemia in primary hypothyroidism and a satisfactory recovery in this response after treatment by desiccated thyroid have been reported (Iwatsubo et al., 1967) . It has been stated that TRH is not entirely specific for TSH.
It constantly releases prolactin with a time course similar to that of TSH release and in women occasionally releases LH (Hall et al., 1973) . Recently a rise of serum GH following TRH injection in patients with acromegaly (Inci and Tsushima, 1972) , chronic renal failure (Gonzalez-Barcoma et al., 1973; Hasegawa et al., 1975) , anorexia nervosa (Maeda et al., 1975a) , and depression (Maeda et al., 1975b) has been reported and the specificity of the action of TRH on pituitary GH release is a matter of discussion. Gagel et al. (1975) observed no significant difference in the urinary excretion of TRH between patients with hyperthyroidism and those with hypothyroidism, and proposed the absence of negative feedback mechanism as to TRH serection. However, there are dispute as to TRH levels in thyroid disorders. Although it has not been known whether TRH may influence the secretion of GH in hypothyroidism, Kato (1974) recently reported that GH response to TRH was increased by propylthiouracil administration and decreased by thyroxine administration in rats. A close relationship between GH and TSH secretion was also proposed. Guansing et al. (1975) observed TSH increase by insulin-induced hypoglycemia in pituitary disorders with decreased secretion of GH. It was also reported that GH may influence the TRH mediated secretion of TSH (Root et al., 1973) . While somatostatin inhibited TSH secretion by TRH in normal people and in patients with primary hypothyroidism (Carr et al., 1975) , the possibility of the participation of somatostatin in the regulation not only of GH but TSH serection in case of TRH administration should also be considered.
Histological descriptions of the pituitary in hypothyroid animals and humans have emphasized a paucity of eosinophils (Russnoticed either an increased number of eosinophils (Uyematsu, 1920) or an eosinophilic adenoma (Langeron et al., 1959) in patients dying of hypothyroidism. From this point of view, Lawrence et al. (1973) reported that some of his patients with Vol.23, No.1 GH RESPONSE TO TRH IN HYPOTHYROIDISM primary hypothyroidism showed an unusually exaggerated GH response to arginine infusion. It is not considered that GH response to TRH is only due to such rare histological changes, since 6 of our 13 patients with hypothyroidism showed an increase in the GH response to TRH administration. This may be due to a mechanism involving hypothalamic hormonal induction of a new pituitary cell population possessing the capability of secreting several pituitary hormones. The mechanism of GH release after TRH administration is not known at the present time. In a patient, A. Ko., serum GH increase after TRH administration was more pronounced than that after insulin-induced hypoglycemia.
A similar response was recently observed in a patient with anorexia nervosa.
The serum GH was markedly increased after TRH administration in this patient, but she showed a low GH response to arginine infusion and insulin-induced hypoglycemia.
Therefore, the possibility must be considered that hypothalamic activity or the response of the pituitary cells is altered. Maeda et at. (1975 a and b) also proposed that altered metabolism of brain monoamines may change the response of GH to TRH in anorexia nervosa and depression. Since it was shown that the content of monoamines in hypothalamus changed in experimental hypothyroidism (Marthynenko et al., 1973) , that GH secretion was shown to be influenced by brain monoamines (Boyd et al., 1970) , and that TRH changed the metabolism of brain catecholamines (Keller et al., 1973; Plotnikoff et al., 1972) , TRH may induce GH secretion by changing the metabolism of catecholamines in the brain in primary hypothyroidism.
